JP2011506966A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011506966A5 JP2011506966A5 JP2010538067A JP2010538067A JP2011506966A5 JP 2011506966 A5 JP2011506966 A5 JP 2011506966A5 JP 2010538067 A JP2010538067 A JP 2010538067A JP 2010538067 A JP2010538067 A JP 2010538067A JP 2011506966 A5 JP2011506966 A5 JP 2011506966A5
- Authority
- JP
- Japan
- Prior art keywords
- value
- output signal
- sample
- analyte concentration
- determined
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012491 analyte Substances 0.000 claims description 193
- 230000006870 function Effects 0.000 claims description 148
- 238000000034 method Methods 0.000 claims description 54
- 238000005534 hematocrit Methods 0.000 claims description 32
- 230000004044 response Effects 0.000 claims description 31
- 239000013060 biological fluid Substances 0.000 claims description 23
- 230000008859 change Effects 0.000 claims description 8
- 238000004891 communication Methods 0.000 claims description 7
- 238000010606 normalization Methods 0.000 claims description 3
- 239000000523 sample Substances 0.000 description 128
- 238000012937 correction Methods 0.000 description 57
- 238000004458 analytical method Methods 0.000 description 51
- 230000003287 optical effect Effects 0.000 description 21
- 238000005259 measurement Methods 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 239000004020 conductor Substances 0.000 description 11
- 238000006479 redox reaction Methods 0.000 description 11
- 238000004082 amperometric method Methods 0.000 description 9
- 230000000875 corresponding effect Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000012472 biological sample Substances 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 230000005284 excitation Effects 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- 238000004832 voltammetry Methods 0.000 description 4
- 238000003928 amperometric titration Methods 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000003869 coulometry Methods 0.000 description 3
- 230000000116 mitigating effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000002277 temperature effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000002848 electrochemical method Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 238000004313 potentiometry Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1271607P | 2007-12-10 | 2007-12-10 | |
| US61/012,716 | 2007-12-10 | ||
| PCT/US2008/085768 WO2009108239A2 (en) | 2007-12-10 | 2008-12-06 | Slope-based compensation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015181883A Division JP6448504B2 (ja) | 2007-12-10 | 2015-09-15 | 勾配ベース補正 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011506966A JP2011506966A (ja) | 2011-03-03 |
| JP2011506966A5 true JP2011506966A5 (enExample) | 2014-08-21 |
| JP5812603B2 JP5812603B2 (ja) | 2015-11-17 |
Family
ID=40845259
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010538067A Active JP5812603B2 (ja) | 2007-12-10 | 2008-12-06 | 勾配ベース補正 |
| JP2015181883A Active JP6448504B2 (ja) | 2007-12-10 | 2015-09-15 | 勾配ベース補正 |
| JP2018107600A Pending JP2018173415A (ja) | 2007-12-10 | 2018-06-05 | 勾配ベース補正 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015181883A Active JP6448504B2 (ja) | 2007-12-10 | 2015-09-15 | 勾配ベース補正 |
| JP2018107600A Pending JP2018173415A (ja) | 2007-12-10 | 2018-06-05 | 勾配ベース補正 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10739350B2 (enExample) |
| EP (2) | EP2223104B1 (enExample) |
| JP (3) | JP5812603B2 (enExample) |
| CN (2) | CN103760356B (enExample) |
| BR (1) | BRPI0820670A2 (enExample) |
| CA (1) | CA2708038A1 (enExample) |
| MX (1) | MX2010006392A (enExample) |
| RU (2) | RU2706691C2 (enExample) |
| TW (2) | TWI534429B (enExample) |
| WO (1) | WO2009108239A2 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010006253A1 (en) | 2008-07-10 | 2010-01-14 | Bayer Healthcare Llc | Systems and methods including amperometric and voltammetric duty cycles |
| BRPI0923342A2 (pt) | 2008-12-08 | 2016-01-12 | Bayer Healthcare Llc | sistema biosensor com ajuste de sinal |
| WO2010077598A1 (en) | 2008-12-08 | 2010-07-08 | Bayer Healthcare Llc | Low total salt reagent compositions and systems for biosensors |
| US9868974B2 (en) | 2009-07-27 | 2018-01-16 | SureSensors Ltd. | Sensor devices |
| TWI391675B (zh) * | 2009-11-13 | 2013-04-01 | Inst Information Industry | 電器使用時間之估算方法、系統與電腦程式產品 |
| US9233788B2 (en) | 2010-01-22 | 2016-01-12 | Bayer Healthcare Llc | Biosensor desiccant system having enhanced measurement performance |
| CA2692097A1 (en) | 2010-02-04 | 2011-08-04 | Ignis Innovation Inc. | Extracting correlation curves for light emitting device |
| CA2793878C (en) | 2010-03-22 | 2018-09-11 | Bayer Healthcare Llc | Residual compensation for a biosensor |
| CN103038636B (zh) * | 2010-06-07 | 2015-01-14 | 拜尔健康护理有限责任公司 | 用于生物传感器的未充满管理系统 |
| BR112012031166A2 (pt) * | 2010-06-07 | 2018-02-27 | Bayer Healthcare Llc | compensação baseada eminclinação incluindo sinais de saída secundários |
| EP2491859A1 (en) * | 2011-02-23 | 2012-08-29 | F. Hoffmann-La Roche AG | Method and system for determining blood glucose characteristics from a discontinuous mode of measurement and computer program product |
| TWI565943B (zh) | 2011-07-22 | 2017-01-11 | 拜耳保健公司 | 具有增進測量性能之生物感測器乾燥劑系統 |
| KR20140063829A (ko) | 2011-09-21 | 2014-05-27 | 바이엘 헬쓰케어, 엘엘씨 | 오차 보상을 갖는 바이오센서 |
| US9903830B2 (en) | 2011-12-29 | 2018-02-27 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte |
| JP6128772B2 (ja) * | 2012-07-27 | 2017-05-17 | 株式会社アプリクス | 化学分析装置の校正方法及び化学分析装置 |
| EP2936124B1 (en) | 2012-12-20 | 2017-03-15 | Roche Diabetes Care GmbH | Methods for evaluating medical measurement curves |
| US9958410B2 (en) * | 2013-03-14 | 2018-05-01 | Ascensia Diabetes Care Holdings Ag | Normalized calibration of analyte concentration determinations |
| JP6280203B2 (ja) * | 2013-03-14 | 2018-02-14 | バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ | 分析物濃度決定のシステム誤差補償 |
| CN105308461B (zh) * | 2013-03-14 | 2017-08-15 | 安晟信医疗科技控股公司 | 样品分析物浓度的逐次逼近法 |
| KR101771829B1 (ko) | 2013-03-15 | 2017-08-25 | 에프. 호프만-라 로슈 아게 | 분석물질을 전기화학적으로 측정하는 디스크립터-기반 방법들 및 그것을 통합한 디바이스들, 장치들 및 시스템들 |
| KR101743382B1 (ko) * | 2013-03-15 | 2017-06-02 | 에프. 호프만-라 로슈 아게 | 전기화학적 측정 중 높은 항산화제 레벨들을 검출하고 그로부터 분석물질 농도를 페일세이프하는 방법들 뿐만 아니라 상기 방법들을 통합한 기기들, 장치들 및 시스템들 |
| GB2512842A (en) * | 2013-04-08 | 2014-10-15 | Sphere Medical Ltd | Sensor calibration method and apparatus |
| FR3005505B1 (fr) * | 2013-05-13 | 2015-05-01 | Biomerieux Sa | Procede de mesure de la concentration plasmatique d'un analyte directement sur un echantillon de sang total |
| US9459231B2 (en) | 2013-08-29 | 2016-10-04 | Lifescan Scotland Limited | Method and system to determine erroneous measurement signals during a test measurement sequence |
| US9243276B2 (en) | 2013-08-29 | 2016-01-26 | Lifescan Scotland Limited | Method and system to determine hematocrit-insensitive glucose values in a fluid sample |
| GB2531728A (en) * | 2014-10-27 | 2016-05-04 | Cilag Gmbh Int | Method for determining diffusion |
| CN104569407B (zh) * | 2014-12-25 | 2017-06-06 | 深圳市康博霖科技有限公司 | 一种真菌毒素检测数据库的构建方法、真菌毒素检测方法、试剂盒及装置 |
| WO2016185352A1 (en) | 2015-05-15 | 2016-11-24 | Ascensia Diabetes Care Holdings Ag | Improved biosensor system analyte measurement |
| CN105021805B (zh) * | 2015-08-21 | 2018-03-06 | 三诺生物传感股份有限公司 | 一种人体生理参数检测结果的校正方法 |
| CN109690304A (zh) | 2016-07-12 | 2019-04-26 | 安晟信医疗科技控股公司 | 通过使用来自两个电极的交替输出信号进行电化学分析的方法 |
| EP3510165B1 (en) * | 2016-09-07 | 2020-12-30 | Roche Diabetes Care GmbH | Methods for testing enzyme based electrochemical sensors |
| CN106596962B (zh) * | 2016-11-01 | 2018-07-03 | 武汉璟泓万方堂医药科技股份有限公司 | 一种基于血糖试纸测试值衰减的code定值修正方法 |
| WO2018097214A1 (ja) | 2016-11-25 | 2018-05-31 | パナソニックヘルスケアホールディングス株式会社 | 生体試料の成分を測定する方法 |
| EP3548881A1 (en) | 2016-12-05 | 2019-10-09 | Ascensia Diabetes Care Holdings AG | Risk factor monitoring |
| TWI652480B (zh) * | 2017-12-28 | 2019-03-01 | 合世生醫科技股份有限公司 | 血液分析物量測方法及裝置 |
| US11382541B2 (en) * | 2018-11-16 | 2022-07-12 | Medtronic Minimed, Inc. | Miniaturized analyte sensor |
| EP3899544A2 (en) * | 2018-12-19 | 2021-10-27 | Gentian AS | Methods for determining the hematocrit level in a sample of whole blood |
| WO2020234728A1 (en) * | 2019-05-21 | 2020-11-26 | Ascensia Diabetes Care Holdings Ag | Compensation system and method for thermistor sensing in an analyte biosensor |
| FR3111064B1 (fr) * | 2020-06-08 | 2022-09-09 | Panoramic Digital Health | procédé de traitement de mesures effectuées par un capteur porté par une personne |
| EP4168779A1 (en) * | 2020-06-18 | 2023-04-26 | Gentian AS | Methods for determining the concentration of an analyte in the plasma fraction of a sample of whole blood |
| JP7090305B1 (ja) * | 2020-12-21 | 2022-06-24 | フジデノロ株式会社 | 計測装置及び計測方法 |
| CN115700377A (zh) * | 2021-07-14 | 2023-02-07 | 疆域康健创新医疗科技成都有限公司 | 医疗检测装置及检测方法 |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3765841A (en) * | 1971-08-06 | 1973-10-16 | Beckman Instruments Inc | Method and apparatus for chemical analysis |
| US4431004A (en) * | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| US4750496A (en) | 1987-01-28 | 1988-06-14 | Xienta, Inc. | Method and apparatus for measuring blood glucose concentration |
| IT1238090B (it) * | 1989-10-25 | 1993-07-07 | Marelli Autronica | Sistema per il controllo del riscaldamento dell'abitacolo di un autoveicolo |
| US5508171A (en) | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
| US5243516A (en) * | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
| JPH04309856A (ja) * | 1991-04-05 | 1992-11-02 | Toshiba Corp | 分析計 |
| FR2701117B1 (fr) | 1993-02-04 | 1995-03-10 | Asulab Sa | Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose. |
| US5366609A (en) | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
| IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| US6153069A (en) | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| US5620579A (en) * | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
| AU722471B2 (en) * | 1995-10-17 | 2000-08-03 | Lifescan, Inc. | Blood glucose strip having reduced sensitivity to hematocrit |
| RU2089906C1 (ru) * | 1995-12-09 | 1997-09-10 | Панасенко Николай Геннадьевич | Способ исследования биологических жидкостей и устройство для его осуществления |
| US5723284A (en) * | 1996-04-01 | 1998-03-03 | Bayer Corporation | Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood |
| US5753429A (en) * | 1996-08-09 | 1998-05-19 | Lifescan, Inc. | Analyte concentration measurement using a hollow frustum |
| DK0958495T3 (da) | 1997-02-06 | 2003-03-10 | Therasense Inc | In vitro analysand sensor med lille volumen |
| US6391558B1 (en) * | 1997-03-18 | 2002-05-21 | Andcare, Inc. | Electrochemical detection of nucleic acid sequences |
| US6391645B1 (en) | 1997-05-12 | 2002-05-21 | Bayer Corporation | Method and apparatus for correcting ambient temperature effect in biosensors |
| US5798031A (en) * | 1997-05-12 | 1998-08-25 | Bayer Corporation | Electrochemical biosensor |
| JP2002505008A (ja) | 1997-06-16 | 2002-02-12 | エラン コーポレーション ピーエルシー | 分析物のｉｎ ｖｉｖｏ測定のためのセンサーをキャリブレートし、試験する方法と、このような方法に用いるためのデバイス |
| US7494816B2 (en) | 1997-12-22 | 2009-02-24 | Roche Diagnostic Operations, Inc. | System and method for determining a temperature during analyte measurement |
| CN1598564B (zh) * | 1997-12-22 | 2010-04-21 | 罗赫诊断手术公司 | 测量仪 |
| ATE258028T1 (de) * | 1998-05-13 | 2004-02-15 | Cygnus Therapeutic Systems | Signalverarbeitung zur messung von physiologischen analyten |
| RU2137126C1 (ru) * | 1998-05-13 | 1999-09-10 | Тверская государственная медицинская академия | Способ исследования биологических жидкостей и устройство для его осуществления |
| AU3849799A (en) | 1998-05-20 | 1999-12-06 | Arkray, Inc. | Method and apparatus for electrochemical measurement using statistical technique |
| US6475372B1 (en) * | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| DE60037592T2 (de) | 1999-09-20 | 2009-01-22 | Roche Diagnostics Gmbh | Methode zur Messung eines Analyten mit Hilfe eines elektrochemischen Biosensors, der durch Anlegen eines Potentials abgeschaltet werden kann |
| JP4050434B2 (ja) * | 1999-11-29 | 2008-02-20 | 松下電器産業株式会社 | サンプルの弁別方法 |
| EP2154522B1 (en) * | 2000-03-29 | 2017-03-01 | Panasonic Healthcare Holdings Co., Ltd. | Biosensor |
| CN102012389B (zh) * | 2001-01-17 | 2013-04-10 | 爱科来株式会社 | 使用传感器的定量分析方法和定量分析装置 |
| EP1455182B1 (en) * | 2001-11-20 | 2015-08-26 | ARKRAY, Inc. | Fail judging method and analyzer |
| AU2003234944A1 (en) * | 2002-08-27 | 2004-03-18 | Bayer Healthcare, Llc | Methods of Determining Glucose Concentration in Whole Blood Samples |
| US7132041B2 (en) * | 2003-02-11 | 2006-11-07 | Bayer Healthcare Llc | Methods of determining the concentration of an analyte in a fluid test sample |
| EP1467206A1 (en) * | 2003-04-08 | 2004-10-13 | Roche Diagnostics GmbH | Biosensor system |
| US7452457B2 (en) * | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
| US7488601B2 (en) * | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
| KR101114020B1 (ko) * | 2003-08-21 | 2012-04-04 | 아가매트릭스, 인코포레이티드 | 전기화학적 성질 분석 방법 및 분석 장치 |
| US8346482B2 (en) * | 2003-08-22 | 2013-01-01 | Fernandez Dennis S | Integrated biosensor and simulation system for diagnosis and therapy |
| JP4449431B2 (ja) | 2003-11-19 | 2010-04-14 | パナソニック株式会社 | 基質濃度の測定方法 |
| JP2005156316A (ja) * | 2003-11-25 | 2005-06-16 | Toshiba Corp | マイクロ波式濃度計 |
| CN1938590B (zh) | 2004-04-19 | 2010-05-05 | 松下电器产业株式会社 | 血液成分的测定方法、该方法中使用的生物传感器和测定装置 |
| EP1751532A1 (en) * | 2004-05-14 | 2007-02-14 | Bayer Healthcare, LLC | Methods for performing hematocrit adjustment in glucose assays and devices for same |
| US8211038B2 (en) * | 2004-09-17 | 2012-07-03 | Abbott Diabetes Care Inc. | Multiple-biosensor article |
| MX2007004331A (es) | 2004-10-12 | 2007-06-05 | Bayer Healthcare Llc | Determinacion de concentracion en una capa barrera de difusion. |
| GB0501826D0 (en) | 2005-01-28 | 2005-03-09 | Melys Diagnostics Ltd | Apparatus for measurement of analyte concentration |
| JP4576624B2 (ja) * | 2005-03-02 | 2010-11-10 | 独立行政法人産業技術総合研究所 | 針一体型バイオセンサー |
| US7517439B2 (en) * | 2005-04-15 | 2009-04-14 | Agamatrix, Inc. | Error detection in analyte measurements based on measurement of system resistance |
| EP1728468A1 (de) * | 2005-06-04 | 2006-12-06 | Roche Diagnostics GmbH | Bewertung von Werten der Blutglucosekonzentration zur Einstellung der Insulindosierung |
| KR101503072B1 (ko) | 2005-07-20 | 2015-03-16 | 바이엘 헬스케어 엘엘씨 | 게이트형 전류 측정법 |
| US8496801B2 (en) | 2005-07-26 | 2013-07-30 | Bayer Healthcare Llc | Method and system for checking an electromechanical biosensor |
| CA2986870A1 (en) | 2005-09-30 | 2007-04-12 | Ascensia Diabetes Care Holdings Ag | Gated voltammetry |
| RU2455925C2 (ru) | 2006-02-27 | 2012-07-20 | БАЙЕР ХЕЛТКЭА ЭлЭлСи | Определение исследуемого вещества с поправкой на температуру для систем биодатчиков |
| CN101055262A (zh) * | 2006-04-11 | 2007-10-17 | 禅谱科技股份有限公司 | 抛弃式电化学感测试片及其制造方法 |
| BRPI0711433A2 (pt) * | 2006-05-08 | 2011-11-16 | Bayer Healthcare Llc | sistema de detecção de saìda anormal para um biosensor |
| RU2342071C2 (ru) * | 2007-01-29 | 2008-12-27 | Игорь Алексеевич Новиков | Способ определения концентрации глюкозы в крови человека |
| US20080248581A1 (en) * | 2007-04-06 | 2008-10-09 | Bayer Healthcare Llc | Method for performing correction of blood glucose assay bias using blood hemoglobin concentration |
| US8551320B2 (en) * | 2008-06-09 | 2013-10-08 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| EP2595526A4 (en) * | 2010-07-19 | 2016-07-13 | Cilag Gmbh Int | SYSTEM AND METHOD FOR MEASURING AN ANALYZES IN A SAMPLE |
-
2008
- 2008-12-06 RU RU2015105353A patent/RU2706691C2/ru active
- 2008-12-06 CN CN201310625384.1A patent/CN103760356B/zh active Active
- 2008-12-06 RU RU2010128653/15A patent/RU2546012C2/ru not_active Application Discontinuation
- 2008-12-06 CA CA2708038A patent/CA2708038A1/en not_active Abandoned
- 2008-12-06 MX MX2010006392A patent/MX2010006392A/es active IP Right Grant
- 2008-12-06 EP EP08872877.9A patent/EP2223104B1/en active Active
- 2008-12-06 JP JP2010538067A patent/JP5812603B2/ja active Active
- 2008-12-06 CN CN2008801200351A patent/CN101999073B/zh active Active
- 2008-12-06 BR BRPI0820670-8A patent/BRPI0820670A2/pt not_active IP Right Cessation
- 2008-12-06 WO PCT/US2008/085768 patent/WO2009108239A2/en not_active Ceased
- 2008-12-06 EP EP18189664.8A patent/EP3438661B1/en not_active Not-in-force
- 2008-12-08 US US12/329,698 patent/US10739350B2/en active Active
- 2008-12-09 TW TW103142985A patent/TWI534429B/zh not_active IP Right Cessation
- 2008-12-09 TW TW97147779A patent/TWI468689B/zh not_active IP Right Cessation
-
2015
- 2015-09-15 JP JP2015181883A patent/JP6448504B2/ja active Active
-
2018
- 2018-06-05 JP JP2018107600A patent/JP2018173415A/ja active Pending
-
2020
- 2020-07-21 US US16/934,963 patent/US20200348306A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6448504B2 (ja) | 勾配ベース補正 | |
| JP2011506966A5 (enExample) | ||
| JP5738770B2 (ja) | 信号調整を持つバイオセンサシステム | |
| TWI431273B (zh) | 生物感測器用之異常輸出偵測系統 | |
| CN103210310B (zh) | 包含次级输出信号的基于斜率的补偿 | |
| JP2012511160A5 (enExample) | ||
| JP2013528289A5 (enExample) | ||
| CN107636452B (zh) | 改进的生物传感器系统分析物测量 | |
| HK1154656B (en) | Slope-based compensation | |
| HK1194136B (zh) | 斜率式补偿 | |
| HK1194136A (en) | Slope-based compensation | |
| HK1179346B (en) | Biosensor system with signal adjustment |